Insider Transactions in Q2 2022 at Lumos Pharma, Inc. (LUMO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2022
|
John C. Mc Kew Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
169
-0.58%
|
$1,183
$7.62 P/Share
|
|
Apr 05
2022
|
John C. Mc Kew Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,214
-7.03%
|
$17,712
$8.32 P/Share
|
|
Apr 01
2022
|
Richard J Hawkins Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,466
-0.2%
|
$13,194
$9.23 P/Share
|
|
Apr 01
2022
|
Lori D Lawley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-2.71%
|
$2,466
$9.23 P/Share
|
|
Apr 01
2022
|
John C. Mc Kew Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,036
-3.19%
|
$9,324
$9.23 P/Share
|
|
Apr 01
2022
|
Bradley J Powers General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-5.79%
|
$3,078
$9.23 P/Share
|